What you should know:
– NeuroFlowa provider of behavioral health technology infrastructure, announced the acquisition of Owla measurement-based care (MBC) technology company.
– This strategic acquisition positions NeuroFlow as a leader in behavioral health measurement and engagement, offering a comprehensive suite of solutions for a broader range of healthcare settings.
– While expanding its reach and service offering, NeuroFlow remains dedicated to collaboration and innovation with its customers. The combined entity will leverage its expertise to deliver exceptional solutions to existing partners in all 50 states, serving more than 17 million people on the platform.
Expanding Neuroflow’s Capabilities
This acquisition builds on NeuroFlow’s prior investments in MBC solutions, including the 2023 acquisition of Capital Solution Design for the U.S. Department of Veterans Affairs. The acquisition of Owl extends NeuroFlow’s capabilities directly to behavioral health provider organizations, enabling seamless integration across primary and specialty care settings. This unified platform provides a comprehensive, 360-degree view of a population’s behavioral health risks.
Overcoming systemic barriers
The combined NeuroFlow-Owl platform addresses a critical challenge: systemic barriers to behavioral health care. By empowering providers, health plans, and the federal government, the platform strives to simplify access to behavioral health care. This merger creates the largest end-to-end behavioral health measurement solution on the market, enabling healthcare providers across the healthcare spectrum to efficiently identify, assess, and coordinate care for patients with behavioral health needs. Additionally, the combined entity demonstrates a strong commitment to quality monitoring and outcomes tracking, a critical area for innovation within the healthcare system.
A Better Understanding of Behavioral Health
The NeuroFlow-Owl platform offers a wealth of data for a more nuanced understanding of behavioral health. With access to over 400 behavioral health assessments, many available in multiple languages, the platform goes beyond simple clinical assessments. Advanced analytics leverage a variety of data sources, including patient-reported information and historical health data, to create a more complete picture of each patient’s acuity. NeuroFlow’s artificial intelligence (AI) and natural language processing (NLP) technology play a critical role, highlighting individuals with suicidal ideation.
Additionally, Owl’s recent impact study with Colorado Access and Aurora Mental Health and Recovery highlights the significant impact of consistent behavioral health measurement. The study demonstrates a clear link between MBC and improved quality of care, while reducing the total cost of care. NeuroFlow is committed to replicating this success on a national scale.
“Owl is dedicated to improving clinical outcomes in partnership with behavioral health providers and demonstrating meaningful savings for the healthcare ecosystem,” says Eric Meier, Chief Executive Officer at Owl, who will serve as NeuroFlow’s President of Behavioral Health Markets. “We're looking forward to expanding the impact of our technology with NeuroFlow's team and resources. Together, our organizations will provide a truly comprehensive solution that simplifies identification of individuals in need of behavioral health care and guides them through their treatment journey. Ultimately, this merger means we can make the greatest impact on behavioral health outcomes across the healthcare spectrum.”
